Skip to content

A trial to evidence based evaluation of the benefits of Nutri Bar a Multi Herbal Formulation, in Pandu Roga or IRON DEFICIENCY ANEMIA.

A clinical study to evaluate the efficacy of nutri bar (Multi Herbal Formulation) in Pandu Roga w.s.r. to IRON DEFICIENCY ANEMIA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010979
Enrollment
100
Registered
2017-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nutri Bar Composition:Sr. No Name of the drug Latin name Part used 1. Green Cauliflower Brassica oleracea Leaves 2. Spinach Spinacia oleracea Leaves 3. Sesame Sesamum indicum Seeds 4

Sponsors

CSIR Palampur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing for trial. 2.Age between 20 -60 years. 3.Patients presenting with clinical features of Pandu Roga / Iron Deficiency Anemia.

Exclusion criteria

Exclusion criteria: 1.Patients not willing for the trial or not ready to give informed consent. 2.Patients of age 3.Patients with Thalassemia major, Aplastic anemia or sickle cell anemia will be excluded. 4.Patients having malignancy, patients suffering from any other major systemic illness necessitating long-term therapy, patients with past history of Atrial Fibrilation, Cononary artery disease, Acute Coronary Syndrome, Myocardial infarction, stroke or severe arrhythmia in the last 6 months will also be excluded. 5.Patients with clinical evidence of Heart Failure, poorly controlled hypertension (Systolic BP > 160mm of Hg&/or Diastolic BP >100 mm of Hg) and Diabetes mellitus will also be excluded. 6.Patients allergic to trial drug preparation.

Design outcomes

Primary

MeasureTime frame
awaitedTimepoint: every 30 days after initiation of the therapy till completion of the trial

Secondary

MeasureTime frame
awaitedTimepoint: every 30 days after initiation of the therapy till completion of the trial

Countries

India

Contacts

Public ContactProf B L Mehra

rajiv gandhi govt post graduate ayurvedic college and hoapital Paprola

mehra_bl@rediffmail.com9418017615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026